Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,"GPCRs, Class A Rhodopsin-like WP455",1.6115861262007276e-05,14.606060606060606,161.18819942130008,"['CX3CR1', 'P2RY12', 'P2RY13', 'CHRM3', 'CYSLTR1', 'GPR65']",0.004512441153362037,0,0,6
2,Complement system WP2806,0.00019325651618831935,8.507575757575758,72.7524673243805,"['FCGR3A', 'CD93', 'C5AR1', 'F13A1', 'VSIG4', 'CD55']",0.02705591226636471,0,0,6
3,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.0025110468382547194,66.94059405940594,400.7770548993648,"['CDKN1A', 'HIF1A']",0.17853450712431057,0,0,2
4,"GPCRs, Other WP117",0.0025504929589187223,14.402985074626866,86.0069734257853,"['CHRM3', 'ADGRE2', 'P2RY13']",0.17853450712431057,0,0,3
5,Nuclear Receptors Meta-Pathway WP2882,0.00479003141426846,3.043869002284844,16.257968846048865,"['SLC7A5', 'DNAJB1', 'BHLHE40', 'PDE4B', 'HMOX1', 'NRG1', 'PLTP', 'FKBP5', 'HSPA1A']",0.19504877363523362,0,0,9
6,Caloric restriction and aging WP4191,0.004925224484122104,33.46534653465346,177.81428451526537,"['NAMPT', 'IGF1']",0.19504877363523362,0,0,2
7,Endochondral Ossification with Skeletal Dysplasias WP4808,0.0055728221038638176,6.42,33.31886070248959,"['SCIN', 'ENPP1', 'PLAT', 'IGF1']",0.19504877363523362,0,0,4
8,Endochondral Ossification WP474,0.0055728221038638176,6.42,33.31886070248959,"['SCIN', 'ENPP1', 'PLAT', 'IGF1']",0.19504877363523362,0,0,4
9,Complement and Coagulation Cascades WP558,0.008680217772537692,8.395522388059701,39.851098838249136,"['C5AR1', 'PLAT', 'CD55']",0.2530014844536596,0,0,3
10,Unfolded protein response WP4925,0.010455957574743466,7.748564867967853,35.337976002067094,"['XBP1', 'HSPA5', 'TXNIP']",0.2530014844536596,0,0,3
11,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.01184426507830976,16.72772277227723,74.20269761669441,"['CDKN1A', 'ENPP1']",0.2530014844536596,0,0,2
12,Macrophage markers WP4146,0.01184426507830976,16.72772277227723,74.20269761669441,"['CD163', 'CD83']",0.2530014844536596,0,0,2
13,Pyrimidine metabolism and related diseases WP4225,0.01184426507830976,16.72772277227723,74.20269761669441,"['DPYD', 'TYMP']",0.2530014844536596,0,0,2
14,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.0131566295776529,2.5546153846153845,11.063603661201773,"['IFNAR2', 'GNG10', 'CDKN1A', 'IL4R', 'ANGPT2', 'DDIT4', 'IGF1', 'JAK3', 'HIF1A']",0.2530014844536596,0,0,9
15,Lung fibrosis WP3624,0.014595569496459057,6.713432835820895,28.377930709093953,"['CEBPB', 'HMOX1', 'IGF1']",0.2530014844536596,0,0,3
16,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.015031424249799783,4.6434482758620685,19.491395686517105,"['CDKN1A', 'HSPA5', 'NRG1', 'YBX3']",0.2530014844536596,0,0,4
17,Biomarkers for pyrimidine metabolism disorders WP4584,0.016264381143449545,13.38019801980198,55.11006213725982,"['DPYD', 'TYMP']",0.2530014844536596,0,0,2
18,Differentiation of white and brown adipocyte WP2895,0.016264381143449545,13.38019801980198,55.11006213725982,"['PLAC8', 'CEBPB']",0.2530014844536596,0,0,2
19,Adipogenesis WP236,0.018845577634118236,3.5144472361809047,13.957546369307643,"['CDKN1A', 'CEBPB', 'NAMPT', 'IGF1', 'HIF1A']",0.27072817966815754,0,0,5
20,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.02127149983106952,11.148514851485148,42.926098195710736,"['CYSLTR1', 'LTC4S']",0.27072817966815754,0,0,2
21,Fluoropyrimidine Activity WP1601,0.02127149983106952,11.148514851485148,42.926098195710736,"['DPYD', 'TYMP']",0.27072817966815754,0,0,2
22,"NAD metabolism, sirtuins and aging WP3630",0.02127149983106952,11.148514851485148,42.926098195710736,"['NAMPT', 'HIF1A']",0.27072817966815754,0,0,2
23,Toll-like Receptor Signaling Pathway WP75,0.02505052725091331,3.2421724004638577,11.953437045343305,"['IFNAR2', 'LY96', 'MAP3K8', 'TLR5', 'MAP2K6']",0.27821417122542996,0,0,5
24,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.025289019949932726,5.296936370777691,19.478874205022862,"['IRAK2', 'LY96', 'PLAT']",0.27821417122542996,0,0,3
25,Regulation of toll-like receptor signaling pathway WP1449,0.026256066363094487,2.8156565656565657,10.248590687029393,"['IFNAR2', 'IRAK2', 'LY96', 'MAP3K8', 'TLR5', 'MAP2K6']",0.27821417122542996,0,0,6
26,Peptide GPCRs WP24,0.026827795082452175,9.554455445544555,34.57104664363161,"['CX3CR1', 'C5AR1']",0.27821417122542996,0,0,2
27,Phytochemical activity on NRF2 transcriptional activation WP3,0.026827795082452175,9.554455445544555,34.57104664363161,"['CEBPB', 'HMOX1']",0.27821417122542996,0,0,2
28,"COVID-19, thrombosis and anticoagulation WP4927",0.029284924979169586,inf,inf,['F13A1'],0.2848841881699905,0,0,1
29,PPAR signaling pathway WP3942,0.0318528540189535,4.791044776119403,16.512950477675346,"['ACSL1', 'OLR1', 'PLTP']",0.2848841881699905,0,0,3
30,Cardiac Progenitor Differentiation WP2406,0.03289713414817906,8.358910891089108,28.540412347069537,"['NRG1', 'IGF1']",0.2848841881699905,0,0,2
31,Differentiation Pathway WP2848,0.03289713414817906,8.358910891089108,28.540412347069537,"['WNT5A', 'IGF1']",0.2848841881699905,0,0,2
32,NRF2 pathway WP2884,0.03357563646289174,3.5389473684210526,12.011026630493388,"['DNAJB1', 'HMOX1', 'NRG1', 'HSPA1A']",0.2848841881699905,0,0,4
33,Oncostatin M Signaling Pathway WP2374,0.03357563646289174,3.5389473684210526,12.011026630493388,"['CEBPB', 'PXN', 'JAK3', 'HIF1A']",0.2848841881699905,0,0,4
34,PI3K-Akt signaling pathway WP4172,0.03657839720736845,2.2214787554366007,7.349312508662225,"['IFNAR2', 'GNG10', 'CDKN1A', 'IL4R', 'ANGPT2', 'DDIT4', 'IGF1', 'JAK3']",0.29850279101471805,0,0,8
35,MECP2 and Associated Rett Syndrome WP3584,0.03893922160254572,3.361,10.908976736773877,"['RBFOX1', 'BCL6', 'IGF1', 'FKBP5']",0.29850279101471805,0,0,4
36,Gastric Cancer Network 2 WP2363,0.03944501166980203,7.429042904290429,24.016964166677205,"['PLAC8', 'RNF144B']",0.29850279101471805,0,0,2
37,Genes controlling nephrogenesis WP4823,0.03944501166980203,7.429042904290429,24.016964166677205,"['ROBO2', 'CXCL12']",0.29850279101471805,0,0,2
38,Purinergic signaling WP4900,0.04643848610039652,6.685148514851485,20.520910519907098,"['P2RY12', 'P2RY13']",0.34217831863450066,0,0,2
39,Vitamin D Receptor Pathway WP2877,0.051051559200376594,3.0536363636363637,9.084321424258626,"['CDKN1A', 'DUSP10', 'BCL6', 'HIF1A']",0.3665240147719345,0,0,4
40,Blood Clotting Cascade WP272,0.05771641934365123,33.30541871921182,94.99416762293453,['PLAT'],0.37582784688889176,0,0,1
41,Thyroxine (Thyroid Hormone) Production WP1981,0.05771641934365123,33.30541871921182,94.99416762293453,['TG'],0.37582784688889176,0,0,1
42,Hfe effect on hepcidin production WP3924,0.05771641934365123,33.30541871921182,94.99416762293453,['HAMP'],0.37582784688889176,0,0,1
43,Monoamine GPCRs WP58,0.05771641934365123,33.30541871921182,94.99416762293453,['CHRM3'],0.37582784688889176,0,0,1
44,NRF2-ARE regulation WP4357,0.061637913274985225,5.569306930693069,15.518751920012026,"['CEBPB', 'HMOX1']",0.3922412662953605,0,0,2
45,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.0687634834792943,2.74,7.335205881024018,"['WNT5A', 'NRG1', 'IGF1', 'MAP2K6']",0.4191116602562505,0,0,4
46,Immune response to tuberculosis WP4197,0.06978526166410078,5.14013709063214,13.684753735048105,"['IFNAR2', 'PTPN2']",0.4191116602562505,0,0,2
47,Pyrimidine metabolism WP4022,0.07102538551785793,3.3492537313432837,8.857831373093171,"['DPYD', 'ENPP1', 'TYMP']",0.4191116602562505,0,0,3
48,Notch Signaling Pathway Netpath WP61,0.07628706160683917,3.2407318247472316,8.339219415255487,"['CDKN1A', 'HIF1A', 'SAP30']",0.4191116602562505,0,0,3
49,Bladder cancer WP2828,0.07826088651579101,4.772277227722772,12.158365695033075,"['CDKN1A', 'TYMP']",0.4191116602562505,0,0,2
50,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.07826088651579101,4.772277227722772,12.158365695033075,"['PTPN1', 'CEBPB']",0.4191116602562505,0,0,2
51,Photodynamic therapy-induced unfolded protein response WP3613,0.07826088651579101,4.772277227722772,12.158365695033075,"['XBP1', 'HSPA5']",0.4191116602562505,0,0,2
52,Senescence and Autophagy in Cancer WP615,0.08072378483051589,2.580769230769231,6.495078740389128,"['CDKN1A', 'CEBPB', 'PLAT', 'IGF1']",0.4191116602562505,0,0,4
53,IL-4 signaling pathway WP395,0.0817154902360618,3.138992537313433,7.861643523719787,"['CEBPB', 'IL4R', 'JAK3']",0.4191116602562505,0,0,3
54,EV release from cardiac cells and their functional effects WP3297,0.08531915940930813,16.65024630541872,40.98218760206973,['CXCL12'],0.4191116602562505,0,0,1
55,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.08531915940930813,16.65024630541872,40.98218760206973,['CEBPB'],0.4191116602562505,0,0,1
56,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.08531915940930813,16.65024630541872,40.98218760206973,['HIF1A'],0.4191116602562505,0,0,1
57,miR-517 relationship with ARCN1 and USP1 WP3596,0.08531915940930813,16.65024630541872,40.98218760206973,['CDKN1A'],0.4191116602562505,0,0,1
58,Neovascularisation processes WP4331,0.08703878965788862,4.453465346534654,10.87269653881126,"['CXCL12', 'HIF1A']",0.42018726041739335,0,0,2
59,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.09305357315995617,2.9534679543459177,7.013245628465922,"['IRAK2', 'MAP3K8', 'MAP2K6']",0.4342500080797955,0,0,3
60,Exercise-induced Circadian Regulation WP410,0.09305357315995617,2.9534679543459177,7.013245628465922,"['CEBPB', 'ERC2', 'ARNTL']",0.4342500080797955,0,0,3
61,Fatty acid beta-oxidation WP143,0.09609420090129903,4.1745049504950495,9.778470224117495,"['GK', 'ACSL1']",0.44108813528465124,0,0,2
62,3q29 copy number variation syndrome WP4906,0.1050002676890489,2.788557213930348,6.284828998300399,"['PXN', 'HIF1A', 'HAMP']",0.4491293912162276,0,0,3
63,Signal transduction through IL1R WP4496,0.10540352905700129,3.9283634245777517,8.838657274556326,"['IRAK2', 'MAP2K6']",0.4491293912162276,0,0,2
64,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.10540352905700129,3.9283634245777517,8.838657274556326,"['ANGPT2', 'HIF1A']",0.4491293912162276,0,0,2
65,Chemokine signaling pathway WP3929,0.10705069595314816,2.0723990321980272,4.630677743057773,"['CX3CR1', 'GNG10', 'CXCL12', 'PXN', 'JAK3']",0.4491293912162276,0,0,5
66,Thiamine metabolic pathways WP4297,0.1121171755442106,11.098522167487685,24.285905453496007,['SLC25A19'],0.4491293912162276,0,0,1
67,Farnesoid X receptor pathway WP2879,0.1121171755442106,11.098522167487685,24.285905453496007,['FKBP5'],0.4491293912162276,0,0,1
68,"GPCRs, Class B Secretin-like WP334",0.1121171755442106,11.098522167487685,24.285905453496007,['ADGRE2'],0.4491293912162276,0,0,1
69,Inflammatory Response Pathway WP453,0.1121171755442106,11.098522167487685,24.285905453496007,['IL4R'],0.4491293912162276,0,0,1
70,DNA damage response (only ATM dependent) WP710,0.1122823478040569,2.2722033898305085,4.968714899235219,"['CDKN1A', 'MLKL', 'BCL6', 'WNT5A']",0.4491293912162276,0,0,4
71,Cardiac Hypertrophic Response WP2795,0.11751454530803643,2.641005498821681,5.6549029180601655,"['NRG1', 'IGF1', 'MAP2K6']",0.4634376434683127,0,0,3
72,Melatonin metabolism and effects WP3298,0.12469518424163734,3.5138092756644084,7.315339957158638,"['PER3', 'ARNTL']",0.4716764323274484,0,0,2
73,Oxidative Damage WP3941,0.12469518424163734,3.5138092756644084,7.315339957158638,"['CDKN1A', 'C5AR1']",0.4716764323274484,0,0,2
74,Type 2 papillary renal cell carcinoma WP4241,0.13463580700478586,3.3376237623762375,6.692542663387237,"['CDKN1A', 'HIF1A']",0.4716764323274484,0,0,2
75,Mitochondrial CIV Assembly WP4922,0.13463580700478586,3.3376237623762375,6.692542663387237,"['PET100', 'COX14']",0.4716764323274484,0,0,2
76,Tryptophan catabolism leading to NAD+ production WP4210,0.13813381232446703,8.322660098522167,16.47497539504024,['NAMPT'],0.4716764323274484,0,0,1
77,Complement Activation WP545,0.13813381232446703,8.322660098522167,16.47497539504024,['CD55'],0.4716764323274484,0,0,1
78,GDNF/RET signaling axis WP4830,0.13813381232446703,8.322660098522167,16.47497539504024,['ROBO2'],0.4716764323274484,0,0,1
79,Hedgehog Signaling Pathway Netpath WP47,0.13813381232446703,8.322660098522167,16.47497539504024,['ARNTL'],0.4716764323274484,0,0,1
80,HIF1A and PPARG regulation of glycolysis WP2456,0.13813381232446703,8.322660098522167,16.47497539504024,['HIF1A'],0.4716764323274484,0,0,1
81,NAD+ metabolism WP3644,0.13813381232446703,8.322660098522167,16.47497539504024,['NAMPT'],0.4716764323274484,0,0,1
82,NOTCH1 regulation of endothelial cell calcification WP3413,0.13813381232446703,8.322660098522167,16.47497539504024,['PLAT'],0.4716764323274484,0,0,1
83,Spinal Cord Injury WP2431,0.1510053845239496,2.3321763276640057,4.408838912428684,"['ZFP36', 'FCGR2A', 'TNFSF13']",0.49193212771164097,0,0,3
84,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.15393642536864527,1.998507462686567,3.739638309088494,"['RYR2', 'CEBPB', 'BHLHE40', 'HIF1A']",0.49193212771164097,0,0,4
85,Hepatitis C and Hepatocellular Carcinoma WP3646,0.1550099480303584,3.0333033303330335,5.6548842157139685,"['CDKN1A', 'HIF1A']",0.49193212771164097,0,0,2
86,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.1550099480303584,3.0333033303330335,5.6548842157139685,"['CDKN1A', 'MAP2K6']",0.49193212771164097,0,0,2
87,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.15803867126196755,2.278833107191316,4.2042545694086,"['HSPA5', 'HSPA1B', 'HSPA1A']",0.49193212771164097,0,0,3
88,Selective expression of chemokine receptors during T-cell polarization WP4494,0.16339174241850932,6.6571428571428575,12.060110848052682,['IL4R'],0.49193212771164097,0,0,1
89,Transcriptional cascade regulating adipogenesis WP4211,0.16339174241850932,6.6571428571428575,12.060110848052682,['CEBPB'],0.49193212771164097,0,0,1
90,Cytokines and Inflammatory Response WP530,0.16339174241850932,6.6571428571428575,12.060110848052682,['IL15'],0.49193212771164097,0,0,1
91,Fatty acid transporters WP5061,0.16339174241850932,6.6571428571428575,12.060110848052682,['ACSL1'],0.49193212771164097,0,0,1
92,Genes targeted by miRNAs in adipocytes WP1992,0.16339174241850932,6.6571428571428575,12.060110848052682,['IGF1'],0.49193212771164097,0,0,1
93,Kynurenine Pathway and links to Cellular Senescence WP5044,0.16339174241850932,6.6571428571428575,12.060110848052682,['CDKN1A'],0.49193212771164097,0,0,1
94,MAPK Signaling Pathway WP382,0.18111142328420674,1.6221896383186705,2.771742708792424,"['DUSP10', 'MAP3K8', 'HSPA1B', 'MAP2K6', 'HSPA1A', 'RASGRP3']",0.5154895502836234,0,0,6
95,CAMKK2  Pathway WP4874,0.18654140710624184,2.6681188118811883,4.480043746726745,"['CHRM3', 'HMOX1']",0.5154895502836234,0,0,2
96,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.18654140710624184,2.6681188118811883,4.480043746726745,"['XBP1', 'HSPA5']",0.5154895502836234,0,0,2
97,Development and heterogeneity of the ILC family WP3893,0.18791298469912307,5.54679802955665,9.273005323868666,['IL15'],0.5154895502836234,0,0,1
98,Galanin receptor pathway WP4970,0.18791298469912307,5.54679802955665,9.273005323868666,['CDKN1A'],0.5154895502836234,0,0,1
99,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.18791298469912307,5.54679802955665,9.273005323868666,['HMOX1'],0.5154895502836234,0,0,1
100,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.18791298469912307,5.54679802955665,9.273005323868666,['ANAPC11'],0.5154895502836234,0,0,1
101,Ferroptosis WP4313,0.197246841514086,2.565118050266565,4.163954417466065,"['ACSL1', 'HMOX1']",0.5154895502836234,0,0,2
102,Insulin Signaling WP481,0.20413151904136959,1.6405557197753473,2.606827931969621,"['PTPN1', 'XBP1', 'ENPP1', 'MAP3K8', 'MAP2K6']",0.5154895502836234,0,0,5
103,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.20802554089938444,2.4697469746974696,3.877735929049211,"['CDKN1A', 'CEBPB']",0.5154895502836234,0,0,2
104,Glucocorticoid Receptor Pathway WP2880,0.20802554089938444,2.4697469746974696,3.877735929049211,"['BHLHE40', 'PDE4B']",0.5154895502836234,0,0,2
105,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.21171892243791673,4.753694581280788,7.380090499076465,['RYR2'],0.5154895502836234,0,0,1
106,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.21171892243791673,4.753694581280788,7.380090499076465,['RAB27A'],0.5154895502836234,0,0,1
107,Globo Sphingolipid Metabolism WP1424,0.21171892243791673,4.753694581280788,7.380090499076465,['ST6GALNAC5'],0.5154895502836234,0,0,1
108,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.21171892243791673,4.753694581280788,7.380090499076465,['ACSL1'],0.5154895502836234,0,0,1
109,NAD+ biosynthetic pathways WP3645,0.21171892243791673,4.753694581280788,7.380090499076465,['NAMPT'],0.5154895502836234,0,0,1
110,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.21171892243791673,4.753694581280788,7.380090499076465,['JAK3'],0.5154895502836234,0,0,1
111,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.21171892243791673,4.753694581280788,7.380090499076465,['IGF1'],0.5154895502836234,0,0,1
112,Omega-3/Omega-6 FA synthesis WP4723,0.21171892243791673,4.753694581280788,7.380090499076465,['ACSL1'],0.5154895502836234,0,0,1
113,Ovarian infertility WP34,0.21171892243791673,4.753694581280788,7.380090499076465,['CEBPB'],0.5154895502836234,0,0,1
114,Overview of nanoparticle effects WP3287,0.21171892243791673,4.753694581280788,7.380090499076465,['HMOX1'],0.5154895502836234,0,0,1
115,RalA downstream regulated genes WP2290,0.21171892243791673,4.753694581280788,7.380090499076465,['YBX3'],0.5154895502836234,0,0,1
116,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.21886411737180497,2.381188118811881,3.6177491345649715,"['IFNAR2', 'CXCL12']",0.5282926971043568,0,0,2
117,Cytoplasmic Ribosomal Proteins WP477,0.2314200389262061,1.6705,2.4448116122125474,"['RPS15A', 'RPL38', 'RPL23A', 'RPL39']",0.5335915361838937,0,0,4
118,Breast cancer pathway WP4262,0.2329639811508673,1.8540630182421227,2.701131430872994,"['CDKN1A', 'WNT5A', 'IGF1']",0.5335915361838937,0,0,3
119,TP53 network WP1742,0.234830321492324,4.1588669950738915,6.025749375388213,['CDKN1A'],0.5335915361838937,0,0,1
120,Triacylglyceride synthesis WP325,0.234830321492324,4.1588669950738915,6.025749375388213,['GK'],0.5335915361838937,0,0,1
121,miRNAs involved in DNA damage response WP1545,0.234830321492324,4.1588669950738915,6.025749375388213,['CDKN1A'],0.5335915361838937,0,0,1
122,Omega-9 FA synthesis WP4724,0.234830321492324,4.1588669950738915,6.025749375388213,['ACSL1'],0.5335915361838937,0,0,1
123,PPAR-alpha pathway WP2878,0.234830321492324,4.1588669950738915,6.025749375388213,['PLTP'],0.5335915361838937,0,0,1
124,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.2408038892853554,1.8200814111261872,2.5913817046880516,"['WNT5A', 'HIF1A', 'MAP2K6']",0.5335915361838937,0,0,3
125,Allograft Rejection WP2328,0.251615762813249,2.1497923985946983,2.9663955682921297,"['CXCL12', 'CD55']",0.5335915361838937,0,0,2
126,Sleep regulation WP3591,0.25726734780294874,3.696223316912972,5.018138668529949,['PER3'],0.5335915361838937,0,0,1
127,Apoptosis Modulation by HSP70 WP384,0.25726734780294874,3.696223316912972,5.018138668529949,['HSPA1A'],0.5335915361838937,0,0,1
128,Vitamin B12 metabolism WP1533,0.25726734780294874,3.696223316912972,5.018138668529949,['PLAT'],0.5335915361838937,0,0,1
129,Wnt signaling in kidney disease WP4150,0.25726734780294874,3.696223316912972,5.018138668529949,['WNT5A'],0.5335915361838937,0,0,1
130,Development of ureteric collection system WP5053,0.25726734780294874,3.696223316912972,5.018138668529949,['ROBO2'],0.5335915361838937,0,0,1
131,Eicosanoid Synthesis WP167,0.25726734780294874,3.696223316912972,5.018138668529949,['LTC4S'],0.5335915361838937,0,0,1
132,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.25726734780294874,3.696223316912972,5.018138668529949,['WNT5A'],0.5335915361838937,0,0,1
133,Iron metabolism in placenta WP2007,0.25726734780294874,3.696223316912972,5.018138668529949,['HAMP'],0.5335915361838937,0,0,1
134,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.25726734780294874,3.696223316912972,5.018138668529949,['MAP2K6'],0.5335915361838937,0,0,1
135,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.25726734780294874,3.696223316912972,5.018138668529949,['HMOX1'],0.5335915361838937,0,0,1
136,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.27353491800299157,2.018901890189019,2.617155000246014,"['ANGPT2', 'PXN']",0.5475796285515769,0,0,2
137,Angiogenesis WP1539,0.27904958481690634,3.3261083743842366,4.245330941544853,['HIF1A'],0.5475796285515769,0,0,1
138,Type II diabetes mellitus WP1584,0.27904958481690634,3.3261083743842366,4.245330941544853,['GK'],0.5475796285515769,0,0,1
139,Imatinib and Chronic Myeloid Leukemia WP3640,0.27904958481690634,3.3261083743842366,4.245330941544853,['PIM1'],0.5475796285515769,0,0,1
140,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.27904958481690634,3.3261083743842366,4.245330941544853,['IL4R'],0.5475796285515769,0,0,1
141,Pre-implantation embryo WP3527,0.27904958481690634,3.3261083743842366,4.245330941544853,['ZFP36'],0.5475796285515769,0,0,1
142,TNF-alpha signaling pathway WP231,0.2805691248447565,1.6671641791044776,2.1188575560367613,"['MAP3K8', 'PYGL', 'MAP2K6']",0.5475796285515769,0,0,3
143,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.2844895633289168,1.959231217239371,2.4628686672116036,"['CDKN1A', 'PFN2']",0.5475796285515769,0,0,2
144,Regulatory circuits of the STAT3 signaling pathway WP4538,0.2844895633289168,1.959231217239371,2.4628686672116036,"['IFNAR2', 'JAK3']",0.5475796285515769,0,0,2
145,IL-18 signaling pathway WP4754,0.2920551862873939,1.414700621752832,1.741231209628089,"['CEBPB', 'NRN1', 'CD83', 'TNFAIP2', 'HMOX1']",0.5475796285515769,0,0,5
146,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.3001960499219606,3.0232870577698163,3.6379803252038925,['MAP2K6'],0.5475796285515769,0,0,1
147,Statin inhibition of cholesterol production WP430,0.3001960499219606,3.0232870577698163,3.6379803252038925,['PLTP'],0.5475796285515769,0,0,1
148,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.3001960499219606,3.0232870577698163,3.6379803252038925,['P4HA1'],0.5475796285515769,0,0,1
149,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.3001960499219606,3.0232870577698163,3.6379803252038925,['IGF1'],0.5475796285515769,0,0,1
150,Fatty Acid Biosynthesis WP357,0.3001960499219606,3.0232870577698163,3.6379803252038925,['ACSL1'],0.5475796285515769,0,0,1
151,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.3001960499219606,3.0232870577698163,3.6379803252038925,['CDKN1A'],0.5475796285515769,0,0,1
152,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.3001960499219606,3.0232870577698163,3.6379803252038925,['HIF1A'],0.5475796285515769,0,0,1
153,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.3001960499219606,3.0232870577698163,3.6379803252038925,['PXN'],0.5475796285515769,0,0,1
154,Circadian rhythm related genes WP3594,0.30294864124594045,1.4661538461538461,1.7508691772465637,"['PER3', 'NAMPT', 'BHLHE40', 'ARNTL']",0.5475796285515769,0,0,4
155,Retinoblastoma gene in cancer WP2446,0.30634406128615704,1.8498349834983498,2.188440664783766,"['CDKN1A', 'SAP30']",0.5475796285515769,0,0,2
156,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.31722750875552674,1.7995718490767996,2.0661533492010737,"['PIM1', 'MAP2K6']",0.5475796285515769,0,0,2
157,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.32072521100878076,2.770935960591133,3.1510268061625064,['TLR5'],0.5475796285515769,0,0,1
158,Transcription factor regulation in adipogenesis WP3599,0.32072521100878076,2.770935960591133,3.1510268061625064,['CEBPB'],0.5475796285515769,0,0,1
159,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.32072521100878076,2.770935960591133,3.1510268061625064,['BCL6'],0.5475796285515769,0,0,1
160,Folate Metabolism WP176,0.32072521100878076,2.770935960591133,3.1510268061625064,['PLAT'],0.5475796285515769,0,0,1
161,Heart Development WP1591,0.32072521100878076,2.770935960591133,3.1510268061625064,['BHLHE40'],0.5475796285515769,0,0,1
162,IL-9 signaling pathway WP22,0.32072521100878076,2.770935960591133,3.1510268061625064,['JAK3'],0.5475796285515769,0,0,1
163,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.32072521100878076,2.770935960591133,3.1510268061625064,['NAMPT'],0.5475796285515769,0,0,1
164,SARS coronavirus and innate immunity WP4912,0.32072521100878076,2.770935960591133,3.1510268061625064,['IFNAR2'],0.5475796285515769,0,0,1
165,Apoptosis WP254,0.3388694340100517,1.7067783701447068,1.846973821700783,"['CASP4', 'IGF1']",0.5610788269153385,0,0,2
166,MET in type 1 papillary renal cell carcinoma WP4205,0.3388694340100517,1.7067783701447068,1.846973821700783,"['CDKN1A', 'JAK3']",0.5610788269153385,0,0,2
167,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.34065500205574123,2.557408109132247,2.754034528819411,['FCGR2A'],0.5610788269153385,0,0,1
168,White fat cell differentiation WP4149,0.34065500205574123,2.557408109132247,2.754034528819411,['CEBPB'],0.5610788269153385,0,0,1
169,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.34065500205574123,2.557408109132247,2.754034528819411,['ANGPT2'],0.5610788269153385,0,0,1
170,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.34065500205574123,2.557408109132247,2.754034528819411,['RAB27A'],0.5610788269153385,0,0,1
171,IL-1 signaling pathway WP195,0.3496143346623246,1.6638613861386138,1.7485929165950402,"['IRAK2', 'MAP2K6']",0.5658497902049184,0,0,2
172,Interferon type I signaling pathways WP585,0.3496143346623246,1.6638613861386138,1.7485929165950402,"['IFNAR2', 'MAP2K6']",0.5658497902049184,0,0,2
173,Pathogenic Escherichia coli infection WP2272,0.3496143346623246,1.6638613861386138,1.7485929165950402,"['LY96', 'TLR5']",0.5658497902049184,0,0,2
174,Overview of interferons-mediated signaling pathway WP4558,0.36000283847432396,2.374384236453202,2.4257738961756825,['IFNAR2'],0.5764803039268926,0,0,1
175,Acute viral myocarditis WP4298,0.3603001899543079,1.6230379135474524,1.6568258851307291,"['TLR5', 'CD55']",0.5764803039268926,0,0,2
176,B Cell Receptor Signaling Pathway WP23,0.3693036791409345,1.4065587555181838,1.401123805033756,"['BCL6', 'RASGRP3', 'MAP2K6']",0.5834716351252014,0,0,3
177,Apoptosis Modulation and Signaling WP1772,0.37092125375816376,1.5841584158415842,1.571113652158252,"['CASP4', 'HSPA1A']",0.5834716351252014,0,0,2
178,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.37092125375816376,1.5841584158415842,1.571113652158252,"['NHSL1', 'TG']",0.5834716351252014,0,0,2
179,Vitamin D in inflammatory diseases WP4482,0.37878563212943694,2.2157635467980294,2.1510296787668692,['MAP2K6'],0.5859667237361456,0,0,1
180,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.37878563212943694,2.2157635467980294,2.1510296787668692,['WNT5A'],0.5859667237361456,0,0,1
181,Oxidative Stress WP408,0.37878563212943694,2.2157635467980294,2.1510296787668692,['HMOX1'],0.5859667237361456,0,0,1
182,ESC Pluripotency Pathways WP3931,0.3814721637129413,1.5470872668662214,1.4909549126508317,"['WNT5A', 'MAP2K6']",0.5868802518660635,0,0,2
183,Head and Neck Squamous Cell Carcinoma WP4674,0.3919479238148725,1.5117011701170118,1.4158990667604356,"['CDKN1A', 'DDIT4']",0.5964424927617625,0,0,2
184,Non-small cell lung cancer WP4255,0.3919479238148725,1.5117011701170118,1.4158990667604356,"['CDKN1A', 'JAK3']",0.5964424927617625,0,0,2
185,Pathways Regulating Hippo Signaling WP4540,0.4126557430898194,1.4455445544554455,1.2795115987826704,"['CDH12', 'CDH18']",0.6144019370696783,0,0,2
186,Aryl Hydrocarbon Receptor Pathway WP2873,0.41472130752203284,1.9545059403071574,1.7202555350859057,['SLC7A5'],0.6144019370696783,0,0,1
187,IL-7 signaling pathway WP205,0.41472130752203284,1.9545059403071574,1.7202555350859057,['JAK3'],0.6144019370696783,0,0,1
188,IL17 signaling pathway WP2112,0.41472130752203284,1.9545059403071574,1.7202555350859057,['CEBPB'],0.6144019370696783,0,0,1
189,Nanoparticle-mediated activation of receptor signaling WP2643,0.41472130752203284,1.9545059403071574,1.7202555350859057,['PXN'],0.6144019370696783,0,0,1
190,The influence of laminopathies on Wnt signaling WP4844,0.4319056233772409,1.845648604269294,1.5495109248055001,['CEBPB'],0.6314750366828079,0,0,1
191,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.433011453725354,1.38490099009901,1.1591498021355597,"['NRG1', 'IGF1']",0.6314750366828079,0,0,2
192,Glioblastoma signaling pathways WP2261,0.433011453725354,1.38490099009901,1.1591498021355597,"['CDKN1A', 'MAP2K6']",0.6314750366828079,0,0,2
193,Hippo-Merlin Signaling Dysregulation WP4541,0.4430482167976275,1.3564356435643565,1.1042426162993502,"['CDH12', 'CDH18']",0.6375867092093469,0,0,2
194,TGF-beta Signaling Pathway WP366,0.44832018228525927,1.2310668877833058,0.9876204675353162,"['CDKN1A', 'LIMK2', 'MAP2K6']",0.6375867092093469,0,0,3
195,ATM Signaling Pathway WP2516,0.4485877918365762,1.7482499351827845,1.401486083586491,['CDKN1A'],0.6375867092093469,0,0,1
196,Toll-like Receptor Signaling related to MyD88 WP3858,0.4485877918365762,1.7482499351827845,1.401486083586491,['TLR5'],0.6375867092093469,0,0,1
197,Glycerophospholipid Biosynthetic Pathway WP2533,0.4485877918365762,1.7482499351827845,1.401486083586491,['GK'],0.6375867092093469,0,0,1
198,Prolactin Signaling Pathway WP2037,0.4529866586756907,1.3291089108910892,1.0525115177474547,"['PTPN1', 'PXN']",0.6405871940868354,0,0,2
199,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.45602378525564746,1.2158718602111394,0.9547151204951826,"['PTPN1', 'MAP3K8', 'MAP2K6']",0.6416415068923683,0,0,3
200,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.46478241605814946,1.6605911330049261,1.2723215206745797,['IFNAR2'],0.6506953824814092,0,0,1
201,Hematopoietic Stem Cell Differentiation WP2849,0.48050367659600834,1.5812807881773399,1.1589529461963843,['PIM1'],0.661822086532292,0,0,1
202,miRNA regulation of prostate cancer signaling pathways WP3981,0.48050367659600834,1.5812807881773399,1.1589529461963843,['CDKN1A'],0.661822086532292,0,0,1
203,Prion disease pathway WP3995,0.48050367659600834,1.5812807881773399,1.1589529461963843,['HSPA5'],0.661822086532292,0,0,1
204,Cell cycle WP179,0.4821846630449556,1.2533158976274985,0.9142038589125079,"['CDKN1A', 'ANAPC11']",0.661822086532292,0,0,2
205,Integrin-mediated Cell Adhesion WP185,0.49170362834826054,1.2299229922992299,0.8730966580831909,"['PXN', 'MAP2K6']",0.667694160252013,0,0,2
206,Aryl Hydrocarbon Receptor Netpath WP2586,0.4957653434991326,1.509180474697716,1.058920346572835,['CDKN1A'],0.667694160252013,0,0,1
207,Integrated Cancer Pathway WP1971,0.4957653434991326,1.509180474697716,1.058920346572835,['CDKN1A'],0.667694160252013,0,0,1
208,T-cell receptor (TCR) signaling pathway WP69,0.5011123383270383,1.2073807380738073,0.8342095060698801,"['CD83', 'MAP3K8']",0.667694160252013,0,0,2
209,Hepatitis B infection WP4666,0.5085933054769141,1.1190675834311588,0.7566089663912513,"['CDKN1A', 'JAK3', 'MAP2K6']",0.667694160252013,0,0,3
210,Target Of Rapamycin (TOR) Signaling WP1471,0.5105807882355322,1.4433497536945812,0.9702289429447818,['DDIT4'],0.667694160252013,0,0,1
211,Disruption of postsynaptic signaling by CNV WP4875,0.5105807882355322,1.4433497536945812,0.9702289429447818,['RYR2'],0.667694160252013,0,0,1
212,Glycogen Synthesis and Degradation WP500,0.5105807882355322,1.4433497536945812,0.9702289429447818,['PYGL'],0.667694160252013,0,0,1
213,MAPK Cascade WP422,0.5105807882355322,1.4433497536945812,0.9702289429447818,['MAP2K6'],0.667694160252013,0,0,1
214,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.5105807882355322,1.4433497536945812,0.9702289429447818,['WNT5A'],0.667694160252013,0,0,1
215,ErbB signaling pathway WP673,0.5195922709993392,1.1646690984887962,0.7625215178035745,"['CDKN1A', 'NRG1']",0.667694160252013,0,0,2
216,G Protein Signaling Pathways WP35,0.5195922709993392,1.1646690984887962,0.7625215178035745,"['GNG10', 'PDE4B']",0.667694160252013,0,0,2
217,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.5249629950315574,1.3830049261083743,0.8912464132832233,['IGF1'],0.667694160252013,0,0,1
218,G1 to S cell cycle control WP45,0.5249629950315574,1.3830049261083743,0.8912464132832233,['CDKN1A'],0.667694160252013,0,0,1
219,NO/cGMP/PKG mediated Neuroprotection WP4008,0.5249629950315574,1.3830049261083743,0.8912464132832233,['TSPO'],0.667694160252013,0,0,1
220,p38 MAPK Signaling Pathway WP400,0.5249629950315574,1.3830049261083743,0.8912464132832233,['MAP2K6'],0.667694160252013,0,0,1
221,Androgen receptor signaling pathway WP138,0.5376129039428448,1.12485316328243,0.6981024188024609,"['CDKN1A', 'LIMK2']",0.667694160252013,0,0,2
222,Mesodermal commitment pathway WP2857,0.5376129039428448,1.12485316328243,0.6981024188024609,"['BHLHE40', 'RPL38']",0.667694160252013,0,0,2
223,Amyotrophic lateral sclerosis (ALS) WP2447,0.5389245722034105,1.327487684729064,0.8206258831031331,['MAP2K6'],0.667694160252013,0,0,1
224,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.5389245722034105,1.327487684729064,0.8206258831031331,['ACSL1'],0.667694160252013,0,0,1
225,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.5389245722034105,1.327487684729064,0.8206258831031331,['MAP2K6'],0.667694160252013,0,0,1
226,Phosphodiesterases in neuronal function WP4222,0.5389245722034105,1.327487684729064,0.8206258831031331,['PDE4B'],0.667694160252013,0,0,1
227,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5524777628393448,1.2762410003789315,0.7572475084491618,['IFNAR2'],0.6814703682599847,0,0,1
228,Gastrin signaling pathway WP4659,0.5722437917259909,1.0528052805280528,0.5876655575594889,"['CDKN1A', 'PXN']",0.7027555336985853,0,0,2
229,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5784061938413633,1.1847290640394088,0.6486141643247886,['PXN'],0.7041466707633988,0,0,1
230,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.5784061938413633,1.1847290640394088,0.6486141643247886,['WNT5A'],0.7041466707633988,0,0,1
231,Genotoxicity pathway WP4286,0.590804187915103,1.1437064718872092,0.6018991367039822,['CDKN1A'],0.7152330940896245,0,0,1
232,Ectoderm Differentiation WP2858,0.5969638712925063,1.0045004500450045,0.518220460776708,"['PLCXD3', 'PIM1']",0.7152330940896245,0,0,2
233,Selenium Micronutrient Network WP15,0.602839322161255,1.1054187192118226,0.5594574786451754,['PLAT'],0.7152330940896245,0,0,1
234,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.602839322161255,1.1054187192118226,0.5594574786451754,['RYR2'],0.7152330940896245,0,0,1
235,IL-2 signaling pathway WP49,0.602839322161255,1.1054187192118226,0.5594574786451754,['JAK3'],0.7152330940896245,0,0,1
236,p53 transcriptional gene network WP4963,0.602839322161255,1.1054187192118226,0.5594574786451754,['CDKN1A'],0.7152330940896245,0,0,1
237,DNA damage response WP707,0.6258629818733071,1.0360221674876848,0.4855046560315841,['CDKN1A'],0.7332285980105689,0,0,1
238,G13 Signaling Pathway WP524,0.6258629818733071,1.0360221674876848,0.4855046560315841,['IQGAP2'],0.7332285980105689,0,0,1
239,miRNA regulation of DNA damage response WP1530,0.6258629818733071,1.0360221674876848,0.4855046560315841,['CDKN1A'],0.7332285980105689,0,0,1
240,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.636871735580884,1.0044782803403494,0.45320754257596013,['CXCL12'],0.7399339666499897,0,0,1
241,RANKL/RANK signaling pathway WP2018,0.636871735580884,1.0044782803403494,0.45320754257596013,['MAP2K6'],0.7399339666499897,0,0,1
242,Endometrial cancer WP4155,0.647558103261852,0.9747899159663865,0.4235917944653388,['CDKN1A'],0.7461574852399941,0,0,1
243,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.647558103261852,0.9747899159663865,0.4235917944653388,['CDKN1A'],0.7461574852399941,0,0,1
244,AMP-activated protein kinase (AMPK) signaling WP1403,0.6579314806751773,0.9467980295566503,0.39638124221244836,['CDKN1A'],0.7519216922002026,0,0,1
245,Modulators of TCR signaling and T cell activation WP5072,0.6579314806751773,0.9467980295566503,0.39638124221244836,['MAP3K8'],0.7519216922002026,0,0,1
246,22q11.2 copy number variation syndrome WP4657,0.6680009911371493,0.9203612479474549,0.37133412309938785,['ARNTL'],0.7541946674129105,0,0,1
247,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.6680009911371493,0.9203612479474549,0.37133412309938785,['MAP3K8'],0.7541946674129105,0,0,1
248,Mitochondrial complex I assembly model OXPHOS system WP4324,0.6680009911371493,0.9203612479474549,0.37133412309938785,['NDUFB3'],0.7541946674129105,0,0,1
249,Small cell lung cancer WP4658,0.6872635883316344,0.8716619134042002,0.32690580033292743,['CDKN1A'],0.7666685447524207,0,0,1
250,Synaptic Vesicle Pathway WP2267,0.6872635883316344,0.8716619134042002,0.32690580033292743,['SYN3'],0.7666685447524207,0,0,1
251,DNA IR-damage and cellular response via ATR WP4016,0.6872635883316344,0.8716619134042002,0.32690580033292743,['BCL6'],0.7666685447524207,0,0,1
252,Calcium Regulation in the Cardiac Cell WP536,0.6916947676983266,0.8375736307807996,0.30873844137302453,"['CHRM3', 'RYR2']",0.7685497418870296,0,0,2
253,Melanoma WP4685,0.7054137236159824,0.8278325123152709,0.2888893792922741,['CDKN1A'],0.777412078151842,0,0,1
254,Osteoblast differentiation WP4787,0.7054137236159824,0.8278325123152709,0.2888893792922741,['WNT5A'],0.777412078151842,0,0,1
255,Myometrial relaxation and contraction pathways WP289,0.7107767571673984,0.8065684617242213,0.275359958577822,"['RYR2', 'PDE4B']",0.777412078151842,0,0,2
256,Regulation of Actin Cytoskeleton WP51,0.7107767571673984,0.8065684617242213,0.275359958577822,"['CHRM3', 'PXN']",0.777412078151842,0,0,2
257,AGE/RAGE pathway WP2324,0.7140917475410604,0.8075213264447916,0.2719278218035245,['HIF1A'],0.7779987910953187,0,0,1
258,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7386287458792028,0.7521271831616659,0.22786434453863894,['CDKN1A'],0.7954463417160645,0,0,1
259,Wnt signaling pathway and pluripotency WP399,0.7386287458792028,0.7521271831616659,0.22786434453863894,['WNT5A'],0.7954463417160645,0,0,1
260,Male infertility WP4673,0.7386287458792028,0.7521271831616659,0.22786434453863894,['ARNTL'],0.7954463417160645,0,0,1
261,Focal Adhesion WP306,0.7514918112530669,0.7423517632662142,0.21208616205192482,"['PXN', 'IGF1']",0.8025361730823986,0,0,2
262,Alzheimer's disease WP2059,0.7538107625738244,0.7192118226600985,0.2032592728670558,['ATP5MD'],0.8025361730823986,0,0,1
263,Wnt signaling WP428,0.7538107625738244,0.7192118226600985,0.2032592728670558,['WNT5A'],0.8025361730823986,0,0,1
264,16p11.2 proximal deletion syndrome WP4949,0.7610693697655663,0.7038046326380882,0.1921603202225837,['MAP2K6'],0.8041487680541832,0,0,1
265,Pathways in clear cell renal cell carcinoma WP4018,0.7610693697655663,0.7038046326380882,0.1921603202225837,['HIF1A'],0.8041487680541832,0,0,1
266,TYROBP causal network in microglia WP3945,0.7681149818166404,0.6890394088669951,0.1817795112245061,['DPYD'],0.8085420861227793,0,0,1
267,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.7749538189725843,0.6748768472906403,0.17206109387320678,['MAP2K6'],0.8126856528551445,0,0,1
268,Ras signaling WP4223,0.7871983542696047,0.6875,0.16450157890311587,"['GNG10', 'RASGRP3']",0.8224460417742138,0,0,2
269,Thermogenesis WP4321,0.8003596037227162,0.6235709638442234,0.13886560429742134,['ACSL1'],0.8330276091621975,0,0,1
270,Leptin signaling pathway WP2034,0.8062517217248412,0.6119321291735085,0.13178525993386528,['PTPN1'],0.8330276091621975,0,0,1
271,Pancreatic adenocarcinoma pathway WP4263,0.8062517217248412,0.6119321291735085,0.13178525993386528,['CDKN1A'],0.8330276091621975,0,0,1
272,VEGFA-VEGFR2 Signaling Pathway WP3888,0.8257437555250988,0.7286195286195286,0.13950934722794808,"['PTPN1', 'PXN', 'TXNIP', 'TMSB10', 'MAP2K6', 'HSPA1A']",0.8500303365699546,0,0,6
273,Nonalcoholic fatty liver disease WP4396,0.8303859530148248,0.6217074537642443,0.11555345858872638,"['XBP1', 'NDUFB3']",0.8516779005280253,0,0,2
274,7q11.23 copy number variation syndrome WP4932,0.838141928104906,0.5502463054187192,0.09715579477092871,['NRG1'],0.8564954009831156,0,0,1
275,Ciliopathies WP4803,0.8475650349498367,0.5323375178770062,0.08804208050961247,['CCDC65'],0.862975308312561,0,0,1
276,EGF/EGFR signaling pathway WP437,0.8717258315598285,0.55747608659171,0.07653049436678028,"['PLSCR1', 'LIMK2']",0.8843595392635942,0,0,2
277,Ebola Virus Pathway on Host WP4217,0.9028444503197597,0.4276757725033587,0.04371060198036562,['SCIN'],0.9122378079793269,0,0,1
278,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9057218236366175,0.42212959454338767,0.0418005633297406,['NDUFB3'],0.9122378079793269,0,0,1
279,Integrated breast cancer pathway WP1984,0.9258876317416493,0.38240348264406004,0.029445985821207336,['RASGRP3'],0.9292062254038057,0,0,1
280,Ciliary landscape WP4352,0.9841258093747844,0.23821509474668295,0.003811807187306184,['IQGAP2'],0.9841258093747844,0,0,1
